Clinical trial

Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose

NCT03440879

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2018-09-21

PhaseNA

Study timeline

Study start (actual)2018-09-21Date precision: day

Registry last updated2023-03-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Resistance Exerciseunresolved

Androgen Deprivation Therapyunresolved

Interventions

ZoladexDRUG · verified · RxNorm: Zoladex

Sponsors & collaborators

Norwegian School of Sport Scienceslead sponsor

University Hospital, Akershuscollaborator

Oslo University Hospitalcollaborator

Copenhagen University Hospital, Rigshospitaletcollaborator

University of Copenhagencollaborator

King's College Londoncollaborator

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03440879 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.